Efficient mobilization of haematopoietic progenitors after a single injection of pegylated recombinant human granulocyte colony‐stimulating factor in mouse strains with distinct marrow‐cell pool sizes
Authors:
Open Access
- 1 September 2000
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 110 (3) , 638-646
Abstract
We have compared the efficacy of a single injection of SD/01, a newly engineered, pegylated form of recombinant human granulocyte colony stimulating factor (rhG‐CSF), with a single injection of glycosylated rhG‐CSF (Filgrastim). SD/01 was administered to regular and recombinant inbred strains of mice (AKR, C57L/J, DBA/2, C57BL/6, AKXL) known to have widely distinct marrow‐cell pool sizes and proliferation kinetics. A single injection of G‐CSF was unable to mobilize granulocyte–macrophage colony‐forming units (CFU‐GM). In sharp contrast, a single dose of SD/01 resulted in massive mobilization of progenitors and stem cells. Although all mice strains showed qualitatively similar mobilization responses, large interstrain differences remained. C57L and C57BL/6 mice mobilized relatively poorly, whereas AKR and DBA/2 mice showed threefold to tenfold superior responses. In order to explain these different phenotypes, we studied the effects of SD/01 in nine AKXL recombinant inbred strains, derived from well‐responding AKR and poorly responding C57L parental strains. The best predictor for SD/01 responsiveness in these strains was marrow cellularity prior to mobilization. Comparison of the AKXL strain distribution pattern for marrow cellularity with loci previously mapped in these strains showed complete concordance with Aat, a serine protease inhibitor mapping to chromosome 12.Keywords
This publication has 30 references indexed in Scilit:
- Progenitor cell mobilization by granulocyte colony-stimulating factor controlled by loci on chromosomes 2 and 11Blood, 2000
- Peripheral blood progenitor cell (PBPC) counts during steady‐state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony‐stimulating factor supported cytotoxic chemotherapy: an update on 100 patientsBritish Journal of Haematology, 1999
- Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor muteinExperimental Hematology, 1999
- The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipientsBone Marrow Transplantation, 1998
- Why pharmacogenomics? Why now?Nature Biotechnology, 1998
- Intrinsic and Extrinsic Control of Hemopoietic Stem Cell Numbers: Mapping of a Stem Cell GeneJournal of Experimental Medicine, 1997
- Genetic dissection of complex traits: guidelines for interpreting and reporting linkage resultsNature Genetics, 1995
- Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation.Journal of Clinical Investigation, 1995
- Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG‐CSF): an analysis of factors correlating with the tempo of engraftment after transplantationBritish Journal of Haematology, 1994
- Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphomaBlood, 1994